Trexquant Investment’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.22M	Buy	+898,767	New	+$4.56M	0.03%	718
2021 Q2	–	Sell	-13,810	Closed	-$107K	–	1158
2021 Q1	$107K	Sell	13,810 -6,403	-32%	-$50.7K	0.01%	1051
2020 Q4	$132K	Sell	20,213 -57,550	-74%	-$411K	0.01%	949
2020 Q3	$517K	Sell	77,763 -50,511	-39%	-$375K	0.03%	666
2020 Q2	$1.07M	Buy	128,274 +109,863	+597%	+$1.02M	0.07%	376
2020 Q1	$141K	Buy	+18,411	New	+$128K	0.01%	1017
2019 Q4	–	Sell	-12,855	Closed	-$95K	–	1066
2019 Q3	$95K	Buy	12,855 +1,213	+10%	+$12K	0.01%	813
2019 Q2	$131K	Sell	11,642 -20,888	-64%	-$219K	0.01%	728
2019 Q1	$350K	Buy	+32,530	New	+$481K	0.02%	695
2018 Q3	–	Sell	-19,670	Closed	-$450K	–	981
2018 Q2	$450K	Sell	19,670 -4,648	-19%	-$119K	0.03%	568
2018 Q1	$692K	Buy	+24,318	New	+$694K	0.05%	525
2017 Q4	–	Sell	-26,110	Closed	-$474K	–	1076
2017 Q3	$474K	Buy	+26,110	New	+$407K	0.12%	293
2017 Q2	–	Sell	-60,979	Closed	-$1.05M	–	845
2017 Q1	$1.05M	Buy	60,979 +44,079	+261%	+$580K	0.14%	236
2016 Q4	$186K	Buy	+16,900	New	+$205K	0.03%	843